Source comparison
Best Peptides for Athletic Performance: Mechanism Comparison
CJC-1295/Ipamorelin GHSR-1a agonism → endogenous GH pulses 2–4× baseline Accelerated muscle protein synthesis, enhanced recovery between training sessions, increased collagen deposition 10–14 days for IGF-1 elevation, 4–6 weeks for measurable lean mass changes
This comparison does not assign a generated winner or score.
- CJC-1295/Ipamorelin
- GHSR-1a agonism → endogenous GH pulses 2–4× baseline
- Accelerated muscle protein synthesis, enhanced recovery between training sessions, increased collagen deposition
- 10–14 days for IGF-1 elevation, 4–6 weeks for measurable lean mass changes
- 2–3× weekly subcutaneous
- Most reliable secretagogue combination for athletes. Preserves natural feedback loops while amplifying anabolic signaling
- MK 677
- Oral ghrelin receptor agonist → sustained 24hr GH elevation
- Similar to injectable secretagogues but with transient insulin resistance and water retention
- 7–10 days for stable serum levels, 3–4 weeks for body composition changes
- Daily oral administration
- Effective alternative for injection-averse athletes, requires dietary carbohydrate management to offset insulin sensitivity changes
- BPC-157
- VEGF upregulation, NO pathway modulation → accelerated angiogenesis and tissue repair
- 30–40% faster tendon/ligament healing, reduced inflammatory duration post-injury
- 48–72 hours for acute inflammation reduction, 2–3 weeks for structural tissue repair
- Daily subcutaneous near injury site
- Most consistent results for soft tissue injuries. Timing relative to damage matters more than cumulative dose
- TB-500
- Actin regulation → enhanced cell migration and reduced fibrosis during repair
- Prevents scar tissue formation, maintains tissue elasticity post-injury
- 5–7 days for cell migration effects, 3–4 weeks for functional strength restoration
- 2× weekly subcutaneous or intramuscular
- Complements BPC-157 for chronic injuries where fibrosis limits function. Less effective as standalone
- SLU PP 332
- ERRα agonism → mitochondrial biogenesis and oxidative capacity increase
- 25–30% mitochondrial density increase, higher lactate threshold and VO2max
- 4–6 weeks for measurable mitochondrial adaptation, 8–12 weeks for performance plateau
- Daily oral or subcutaneous
- Represents future of endurance enhancement. Mechanism is fundamentally different from EPO or oxygen-carrying compounds
- Cerebrolysin
- BDNF support → enhanced neuroplasticity and motor learning
- Faster skill acquisition, improved movement economy, reduced mental fatigue in precision sports
- 10–14 days for cognitive effects, 4–6 weeks for motor pattern optimization
- 3–5× weekly intramuscular
- Niche application for technical athletes. Minimal impact on strength or raw endurance